NCT05809011 Efficacy and Safety of corticoSTEROids Added to Standard Therapy in Patients With Acute Heart Failure (STERO-AHF) Status RECRUITING Phase PHASE2/PHASE3
NCT05805930 Therapeutic Approach in Colchicine-resistant Recurrent pEricarditis in Children Status NOT_YET_RECRUITING Phase PHASE3
NCT05800366 A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma Status RECRUITING Phase PHASE2
NCT05772871 The Efficacy and Safety of Prednisone Combined With Huaiqihuang Granule for Primary Nephrotic Syndrome in Children Status RECRUITING Phase PHASE4
NCT05761171 A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05689021 CJNJ-67652000 and Prednisone for Treatment of Metastatic Castration-Resistant Prostate Cancer and SPOP Gene Mutations Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05681481 A Phase 3 Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid Status TERMINATED Phase PHASE3
NCT05678933 AC-CHOP Versus CHOP in Patients With Previously Untreated PTCL-TFH Status ENROLLING_BY_INVITATION Phase PHASE3
NCT05675410 A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab Status RECRUITING Phase PHASE3
NCT05673785 A Study of Brentuximab Vedotin in Combination With Cyclophosphamide, Doxorubicin (Hydroxydaunorubicin), Prednisone (CHP) in Chinese Participants With CD30-Positive (CD30+) Peripheral T-Cell Lymphomas (PTCL) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05666336 Multi-omics Studies on the Efficacy of Telitacicept in Chinese SLE Patients Status RECRUITING Phase PHASE4
NCT05660473 Pediatric-inspired Regimen Combined With Venetoclax for Adolescent and Adult Patients With de Novo Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia Status RECRUITING Phase PHASE2
NCT05645718 Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric With B-Cell Lineage Acute Lymphocytic Leukemia Status RECRUITING Phase PHASE2
NCT05644210 Telitacicept Followed With Rituximab Therapy on APS Secondary to SLE Status RECRUITING Phase N/A
NCT05627557 A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic Syndrome Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05605899 Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05600686 Loncastuximab Tesirine and Rituximab Followed by DA-EPOCH-R for Treating Patients With High-Risk Diffuse Large B-cell Lymphoma Status RECRUITING Phase PHASE2
NCT05594784 Olverembatinib Combined With Reduced-Intensity Chemotherapy and Venetoclax for de Novo Ph+ ALL Status COMPLETED Phase PHASE2